Lung Cancer Screening Research and Guidelines

This session provided an overview of the evidence to support lung cancer screening, including its evolution and the slight variances in different guidelines/recommendations by organizations.

Restarting a Lung Cancer Screening Program in a Post-COVID-19 World

This session provided an overview of how one system (Vanderbilt) reopened their lung cancer screening program after the height of the COVID-19 pandemic.  This included topics on risk mitigation, rescheduling appointments, and the use of telemedicine for shared decision-making.

Perceived Risks: What Patients Really Think About Lung Cancer Screening

This session will help participants better understand what makes patients decide to receive lung cancer screening or decline to receive their screening.  It will also introduce the notion of stigma and bias and how both factor into a patient’s decision to screen or not to screen.  There will also be discussion around how the stress of COVID-19 may make it difficult for individuals to quit smoking.

Lung Cancer Screening and Health Disparities

Shared Decision-Making and Decision Aids

Tobacco Cessation in the Context of Lung Cancer Screening

Adopting Empathic Communication in the Context of Assessing Smoking Behavior

Proven Smoking Cessation Interventions, Resources, and Cessation Medication

Survivorship: How Stigma and Nihilism Influences Quality of Life, Cancer Care and Prognosis

Lung Cancer Screening: A teachable moment to help smokers quit

Lung Nodule Management

Motivational Interviewing

USPSTF Final Lung Cancer Screening Recommendations: Impact and Implications

Top Tips to Sustain Success in Your Lung Cancer Screening Programs